ASBURY AUTOMOTIVE GROUP INC financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data ASBURY AUTOMOTIVE GROUP INC files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2021	FY2023	FY2024	FY2025
Revenue	6,528	6,457	6,874	7,210	7,132	9,838	15,434	14,803	17,189	17,999
Cost of revenue	5,469	5,401	5,771	6,041	5,908	7,936	12,333	12,047	14,240	14,927
Gross profit	1,059	1,056	1,103	1,169	1,223	1,902	3,101	2,756	2,949	3,072
Selling, general and administrative	733	730	756	800	782	1,074	1,763	1,617	1,889	1,988
Operating income	298	288	311	325	371	792	1,273	954	836	861
Interest expense						102	161	166
Other non-operating income	-30	-78.6	-86.1	-81.1	-32.7	-94.1	46.5	-152	-260	-198
Pre-tax income	268	209	225	244	338	698	1,319	801	575	662
Income tax	101	70	56.8	59.5	83.8	165	322	199	145	170
Income from continuing operations	167	139
Net income	167	139	168	184	254	532	997	603	430	492
EBITDA	329	320	345	361	409	834	1,342	1,021	911	943
EPS, basic	7.43	6.69	8.36	9.65	13.25	26.75	44.78	28.87	21.58	25.20
EPS, diluted	7.40	6.62	8.28	9.55	13.18	26.49	44.61	28.74	21.50	25.13
Shares, basic (weighted)	22.5	20.8	20.1	19.1	19.2	19.9	22.3	20.9	19.9	19.5
Shares, diluted (weighted)	22.6	21	20.3	19.3	19.3	20.1	22.4	21	20	19.6

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2021	FY2023	FY2024	FY2025
Cash and equivalents	3.4	4.7	8.3	3.5	1.4	179	235	45.7	69.4	40.4
Short-term investments					0	11	5.4	6.2	14.4	0.5
Receivables	138	129	130	136	156	230	172	226	286	295
Inventory	895	826	1,068	985	875	718	959	1,768	1,979	2,136
Other current assets	97	119	122	129	184	204	288	389	352	401
Total current assets	1,332	1,302	1,553	1,603	1,406	1,929	1,910	3,057	3,138	3,380
Property, plant and equipment	815	834	886	910	956	1,990	1,941	2,316	2,551	3,070
Lease right-of-use assets			0	65.6	317	261	235	242	220	241
Goodwill	128	161	181	202	562	2,272	1,783	2,009	2,045	2,281
Other non-current assets	11.7	10	9.3	10	9.6	22.1	117	113	138	133
Total assets	2,336	2,357	2,695	2,911	3,676	8,003	8,021	10,159	10,337	11,618
Accounts payable	81.9	92.4	81.9	81.7	97.6	164	147	156	169	152
Accrued liabilities	24.5	24.9	27.6	3.3	2.8	7	7	7.3	7.5	8
Deferred revenue				5.1	0	182	219	229	236	244
Short-term debt	14	12.9	38.8	32.4	36.6	62.5	84.5	84.9	115	479
Total current liabilities	1,105	1,058	1,303	1,247	1,223	1,598	1,033	2,876	2,836	3,560
Long-term debt	913	863	867	907	1,165	3,520	3,217	3,121	3,024	3,093
Lease liabilities			0	52.6	297	242	218	222	200	222
Other non-current liabilities	29.9	29.2	30.7	32.4	50.9	60.8	53.5	51.7	56.4	57.1
Total liabilities	2,056	1,963	2,222	2,265	2,771	5,887	5,118	6,915	6,835	7,726
Total debt	936	883	913	922	1,185	3,405	3,293	2,228	3,139	3,572
Paid-in capital	549	564	573	583	596	1,279	1,281	1,288	1,305	1,328
Retained earnings	612	750	923	1,095	1,349	1,881	2,610	2,962	3,219	3,616
Treasury stock	-880	-919	-1,023	-1,029	-1,034	-1,044	-1,063	-1,067	-1,079	-1,093
Other comprehensive income	-2.1	-0.9	0.6	-2.9	-5.6	-0.5	74.4	61.1	56.8	40.6
Shareholders' equity	280	394	473	646	906	2,116	2,904	3,244	3,502	3,892
Total equity	280	394	473	646	906	2,116	2,904	3,244	3,502	3,892
Total liabilities and equity	2,336	2,357	2,695	2,911	3,676	8,003	8,021	10,159	10,337	11,618

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2021	FY2023	FY2024	FY2025
Net income	167	139	168	184	254	532	997	603	430	492
Depreciation and amortization	30.7	32.1	33.7	36.2	38.5	41.9	69	67.7	75	82.4
Stock-based compensation	12	13.6	10.5	12.5	12.6	16.2	20.6	23.5	26.7	27.7
Deferred income tax	6.1	2.6	5.9	5.2	9.4	30.6	149	39.8	52.7	28.4
Change in receivables	-19.5	10.2	-1.5	-6	-19.1	35.3	47.6	-54.6	-60	-9.3
Change in inventory	105	252	-24.4	212	428	671	-275	-576	-230	72.7
Change in payables	31.4	-2.6	-16.2	10.7	121	39.2	-69.8	120	12.8	-36
Cash from operations	143	266	10.1	350	653	1,164	696	313	671	775
Capital expenditures	-81.4	-42.3	-40.3	-57.6		-74.2	-94.6	-142
Acquisitions	0	-80.1	-91.3	-210	-954	-3,660	-5	-1,500	-4.7	-1,762
Purchases of investments				0	0	-1.1	-202	-195	-165	-189
Sales and maturities of investments				0	0	0.8	69.7	60.3	150	133
Cash from investing	4.9	-128	-150	-228	-821	-3,917	465	-1,678	-137	-1,457
Debt issued	0	0	50.7	97.7	1,875	2,274	0	0	0	547
Stock issued	0			0	0	667	1.4	0	0
Share buybacks	-216	-39.6	-110	-20.5	-5.1	-10.4	-9.2	-11.4	-10.2	-12.8
Cash from financing	-147	-137	143	-127	166	2,931	-1,104	1,176	-510	653
Net change in cash	0.6	1.3	3.6	-4.8	-2.1	178	56.4	-190	23.7	-29
Free cash flow	61.1	224	-30.2	292		1,090	601	171
Interest paid	73.8	76	82.5	91.2	62.6	92.2	147	149	270	275
Income taxes paid	79.6	103	40.4	48.4	48.6	114	198	192	78.7	140

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $185.15 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	17.1%	Gross profit / revenue.
Operating margin	4.4%	Operating income / revenue.
EBITDA margin	4.9%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	3.8%	Pre-tax income / revenue.
Net margin	2.8%	Net income / revenue.
Operating cash flow margin	4.5%	Cash from operations / revenue.
Effective tax rate	25.6%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	13.0%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	4.5%	Net income / average total assets.
Return on invested capital (ROIC)	7.9%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
SG&A / revenue	11.5%	Selling, general and administrative expense / revenue.
Stock-based pay / revenue	0.2%	Stock-based compensation (from the cash flow statement) / revenue.
D&A / revenue	0.5%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	4.7%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	5.3%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	20.3%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	4.2%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	-0.3%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	20.2%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	3.0%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	-12.2%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y	18.3%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y	3.6%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	-11.1%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	18.2%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	14.3%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	-21.0%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y	14.1%	Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y	16.9%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y	-17.4%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y	13.8%	Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	15.5%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	3.7%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	3.5%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	11.1%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	10.3%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	33.9%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	12.4%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	13.1%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	25.9%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	-2.0%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	-4.4%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	0.3%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	0.91x	Current assets / current liabilities.
Quick ratio	0.09x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.01x	(Cash + short-term investments) / current liabilities.
Debt / equity	0.88x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	30.3%	Total debt / total assets.
Liabilities / assets	65.6%	Total liabilities / total assets.
Net debt	$3.42B	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	3.92x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Working capital	-$305.3M	Current assets - current liabilities.
Goodwill and intangibles / assets	19.9%	(Goodwill + intangible assets) / total assets.
Tangible book value	$1.65B	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	1.58x	Revenue / average total assets.
Fixed asset turnover	5.64x	Revenue / average property, plant and equipment.
Inventory turnover	7.07x	Cost of revenue / average inventory.
Days inventory	52 days	365 x average inventory / cost of revenue.
Receivables turnover	69.8x	Revenue / average receivables.
Days sales outstanding	5 days	365 x average receivables / revenue.
Days payables	20 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	36 days	Days inventory + days sales outstanding - days payables.

Per share

Metric	Value	How it is calculated
EPS, diluted	$27.84	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$982.24	Revenue / diluted weighted shares.
Operating cash flow per share	$44.34	Cash from operations / diluted weighted shares.
Book value per share	$214.38	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$90.36	Tangible book value / shares outstanding.
Cash per share	$1.95	(Cash + short-term investments) / shares outstanding.

Valuation

Metric	Value	How it is calculated
Market cap	$3.32B	Share price x shares outstanding.
Enterprise value	$6.75B	Market cap + total debt - cash - short-term investments.
P/E	6.52x	Market cap / net income. Only when net income is positive.
P/S	0.18x	Market cap / revenue.
P/B	0.85x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	2.01x	Market cap / tangible book value, when positive.
P/OCF	4.10x	Market cap / cash from operations, when positive.
EV/Sales	0.38x	Enterprise value / revenue.
EV/EBIT	8.62x	Enterprise value / operating income, when both are positive.
EV/EBITDA	7.73x	Enterprise value / EBITDA, when both are positive.
Earnings yield	15.3%	Net income / market cap (the inverse of P/E).
Shareholder yield	8.7%	(Dividends paid + share buybacks) / market cap.

What was ASBURY AUTOMOTIVE GROUP INC's revenue in fiscal 2025?

ASBURY AUTOMOTIVE GROUP INC reported revenue of $18.00B for fiscal 2025, 4.7% higher than the year before.

Was ASBURY AUTOMOTIVE GROUP INC profitable in fiscal 2025?

Yes. Net income was $492.0M, a net margin of 2.7%.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to ASBURY AUTOMOTIVE GROUP INC